Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-10T06:03:51.357Z Has data issue: false hasContentIssue false

16 Superior Verbal Learning and Memory in Pediatric Brain Tumor Survivors Treated with Proton Versus Photon Radiotherapy

Published online by Cambridge University Press:  21 December 2023

Lisa E. Mash
Affiliation:
Department of Pediatrics, Division of Psychology, Baylor College of Medicine, Houston, TX, USA. Psychology Service, Texas Children’s Hospital, Houston, TX, USA.
Lisa S. Kahalley
Affiliation:
Department of Pediatrics, Division of Psychology, Baylor College of Medicine, Houston, TX, USA. Psychology Service, Texas Children’s Hospital, Houston, TX, USA. Texas Children’s Hospital Cancer and Hematology Centers, Texas Children’s Hospital, Houston, TX, USA.
M. Fatih Okcu
Affiliation:
Department of Pediatrics, Division of Hematology Oncology, Baylor College of Medicine, Houston, TX, USA.
David R. Grosshans
Affiliation:
Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Arnold C. Paulino
Affiliation:
Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Heather Stancel
Affiliation:
Department of Pediatrics, Division of Psychology, Baylor College of Medicine, Houston, TX, USA. Psychology Service, Texas Children’s Hospital, Houston, TX, USA.
Luz A. De Leon
Affiliation:
Department of Pediatrics, Division of Psychology, Baylor College of Medicine, Houston, TX, USA. Psychology Service, Texas Children’s Hospital, Houston, TX, USA.
Elisabeth A. Wilde*
Affiliation:
Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Nilesh Desai
Affiliation:
Department of Pediatrics, Division of Neuroradiology, Baylor College of Medicine, Houston, TX, USA.
Zili D. Chu
Affiliation:
Department of Pediatrics, Division of Neuroradiology, Baylor College of Medicine, Houston, TX, USA.
William E. Whitehead
Affiliation:
Department of Pediatrics, Division of Neurosurgery, Baylor College of Medicine, Houston, TX, USA
Murali Chintagumpala
Affiliation:
Department of Pediatrics, Division of Hematology Oncology, Baylor College of Medicine, Houston, TX, USA.
Kimberly P Raghubar
Affiliation:
Department of Pediatrics, Division of Psychology, Baylor College of Medicine, Houston, TX, USA. Psychology Service, Texas Children’s Hospital, Houston, TX, USA.
*
Correspondence: Lisa E. Mash, PhD Department of Pediatrics, Division of Psychology, Baylor College of Medicine Psychology Service, Texas Children’s Hospital lxmash@texaschildrens.org
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Radiotherapy for pediatric brain tumor has been associated with late cognitive effects. Compared to conventional photon radiotherapy (XRT), proton radiotherapy (PRT) delivers less radiation to healthy brain tissue. PRT has been associated with improved long term cognitive outcomes compared to XRT. However, there is limited research comparing the effects of XRT and PRT on verbal memory outcomes.

Participants and Methods:

Survivors of pediatric brain tumor treated with either XRT (n = 29) or PRT (n = 51) completed neuropsychological testing > 1 year following radiotherapy. XRT and PRT groups were similar with respect to sex, handedness, race, age at diagnosis, age at evaluation, tumor characteristics, and treatment history (i.e., craniospinal irradiation, craniotomy, shunting, chemotherapy, radiation dose). Verbal learning and memory were assessed using the age-appropriate version of the California Verbal Learning Test (CVLT-II/CVLT-C). Measures of intellectual functioning, executive functioning, attention and adaptive behavior were also collected. Performance on neuropsychological measures was compared between treatment groups (XRT vs. PRT) using analysis of covariance (ANCOVA). On the CVLT, each participant was classified as having an encoding deficit profile (i.e., impaired learning, recall, and recognition), retrieval deficit profile (i.e., impaired recall but intact recognition), intact profile, or other profile. Chi-squared tests of independence were used to compare the probability of each memory profile between treatment groups. Pearson correlation was used to examine associations between memory performance and strategy use, intellectual functioning, adaptive behavior, attention, and executive functioning.

Results:

Overall, patients receiving PRT demonstrated superior verbal learning (CVLT Trials 1-5; t(76) = 2.61, p = .011), recall (CVLT Long Delay Free; t(76) = 3.57, p = .001) and strategy use (CVLT Semantic Clustering; t(76) = 2.29, p = .025) compared to those treated with XRT. Intact performance was more likely in the PRT group than the XRT group (71% PRT, 38% XRT; X2 = 8.14, p = .004). Encoding and retrieval deficits were both more common in the XRT group, with encoding problems being most prevalent (Encoding Deficits: 31% XRT, 12% PRT, X2 = 4.51, p = .034; Retrieval Deficits: 17% XRT, 4% PRT, X2 = 4.11, p = .043). Across all participants, semantic clustering predicted better encoding (r = .28, p = .011) and retrieval (r = .26, p = .022). Better encoding predicted higher intellectual (r = .56, p < .001) and adaptive functioning (r = .30, p = .011), and fewer parent-reported concerns about day-today attention (r = -.36, p = .002), and cognitive regulation (r = -.35, p = .002).

Conclusions:

Results suggest that PRT is associated with superior verbal memory outcomes compared to XRT, which may be driven by encoding skills and use of learning strategies. Moreover, encoding ability predicted general intellectual ability and day-to-day functioning. Future work may help to clarify underlying neural mechanisms associated with verbal memory decline following radiotherapy, which will better inform treatment approaches for survivors of pediatric brain tumor.

Type
Poster Session 01: Medical | Neurological Disorders | Neuropsychiatry | Psychopharmacology
Copyright
Copyright © INS. Published by Cambridge University Press, 2023